Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with…
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and LYSA-LYSARC-CALYM announced that they have entered a strategic research collaboration to study valemetostat (DS-3201),…
Read More...
Read More...
